137 related articles for article (PubMed ID: 1423879)
1. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer.
Stopera SA; Murphy LC; Bird RP
Carcinogenesis; 1992 Nov; 13(11):2081-5. PubMed ID: 1423879
[TBL] [Abstract][Full Text] [Related]
2. Expression of ras oncogene mRNA and protein in aberrant crypt foci.
Stopera SA; Bird RP
Carcinogenesis; 1992 Oct; 13(10):1863-8. PubMed ID: 1423846
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
4. Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane.
Davies MJ; Rumsby PC
Teratog Carcinog Mutagen; 1998; 18(4):183-97. PubMed ID: 9804274
[TBL] [Abstract][Full Text] [Related]
5. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
6. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
Hu Y; Le Leu RK; Young GP
Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutations in putative preneoplastic lesions in human colon.
Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
[TBL] [Abstract][Full Text] [Related]
9. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci.
Stopera SA; Bird RP
Cytobios; 1993; 73(293):73-88. PubMed ID: 8319499
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
12. Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci: differential expression of c-myc and c-fos MRNA and protein.
Stopera SA; Bird RP
Int J Cancer; 1993 Mar; 53(5):798-803. PubMed ID: 8449605
[TBL] [Abstract][Full Text] [Related]
13. Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet.
Shivapurkar N; Tang Z; Ferreira A; Nasim S; Garett C; Alabaster O
Carcinogenesis; 1994 Apr; 15(4):775-8. PubMed ID: 8149495
[TBL] [Abstract][Full Text] [Related]
14. Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis.
Luceri C; De Filippo C; Caderni G; Gambacciani L; Salvadori M; Giannini A; Dolara P
Carcinogenesis; 2000 Sep; 21(9):1753-6. PubMed ID: 10964108
[TBL] [Abstract][Full Text] [Related]
15. Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer.
Stopera SA; Davie JR; Bird RP
Carcinogenesis; 1992 Apr; 13(4):573-8. PubMed ID: 1576709
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci.
Magnuson BA; South EH; Exon JH; Dashwood RH; Xu M; Hendrix K; Hubele S
Cancer Lett; 2000 Dec; 161(2):185-93. PubMed ID: 11090968
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa.
Jacoby RF; Llor X; Teng BB; Davidson NO; Brasitus TA
J Clin Invest; 1991 Feb; 87(2):624-30. PubMed ID: 1991846
[TBL] [Abstract][Full Text] [Related]
18. Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts in the rat.
Tachino N; Hayashi R; Liew C; Bailey G; Dashwood R
Mol Carcinog; 1995 Apr; 12(4):187-92. PubMed ID: 7727039
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon.
Zaidi NH; Pretlow TP; O'Riordan MA; Dumenco LL; Allay E; Gerson SL
Carcinogenesis; 1995 Mar; 16(3):451-6. PubMed ID: 7697797
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.
Calcagno SR; Li S; Colon M; Kreinest PA; Thompson EA; Fields AP; Murray NR
Int J Cancer; 2008 Jun; 122(11):2462-70. PubMed ID: 18271008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
